CNO Financial Group Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Operating Earnings per Share (EPS): $1.26, up 45% year-over-year.

Sales Growth: 16th consecutive quarter of sales growth; total new annualized premiums increased by 7%.

Book Value per Share: $39.92, up 5%.

Return on Equity (ROE): 14.1% on a trailing 12-month basis.

Expense Ratio: 18.4%, with expectations of normalization in the latter half of the year.

Shareholder Returns: $77 million returned to shareholders, including $60 million in share repurchases.

2Strategic Updates and Business Highlights

Sales Performance: Strong across both Consumer and Worksite divisions. Notable records in Medicare Supplement (NAP up 52%) and annuities (collected premiums of $536 million, up 3%).

Agent Growth: Producing agent count increased by 3%, marking the 14th consecutive quarter of growth.

Product Diversification: Continued focus on a diversified product portfolio addressing health, wealth, and income protection needs, with a strong emphasis on middle-income consumers.

Investment Strategy: Net investment income increased by 8% year-over-year, with a new money rate of 6.16%.

3Forward Guidance and Outlook

Operating EPS Guidance: Increased to a range of $4.60 to $4.80 for the full year, reflecting an 8% increase at the midpoint.

Expense Ratio Guidance: Narrowed to 18.8% to 19.0%.

Effective Tax Rate: Lowered to approximately 21.5%.

Long-term ROE Goal: Expected to exceed 12% by year-end 2027, with intentions to establish new targets in February 2027.

4Bad News, Challenges, or Points of Concern

Life Insurance Sales: Life NAP decreased by 9% due to lower direct-to-consumer sales, with expectations of variability as the company transitions marketing strategies.

Consumer NAP Deceleration: Concerns about potential deceleration in consumer NAP growth, particularly as comparisons become more challenging in upcoming quarters.

Market Competition: Increased competition in the annuity market, though CNO's captive distribution model provides some insulation from broader market pressures.

5Notable Q&A Insights

Long Term Care Margins: Margins have improved, with claims experience trending better than expected; further analysis will be conducted in the upcoming quarterly review.

Worksite Business Growth: Continued growth attributed to geographic expansion and improved sales force maturity, with no major strategic changes.

Medicare Supplement Margins: Recent favorable claims reserve development of approximately $4 million noted, but future margins may need adjustment based on this one-time benefit.

Capital Deployment: No changes in capital deployment strategy; focus remains on reinvestment in business and shareholder returns, with ongoing evaluation of opportunities in Bermuda. Overall, CNO Financial Group reported a strong quarter with significant growth in operating earnings and sales, while also addressing potential challenges in specific product lines and market competition. The company remains optimistic about its long-term growth trajectory and strategic initiatives.